Publications by authors named "N Mbah"

Article Synopsis
  • H3K27M diffuse midline gliomas (DMG) consist of two main types of cells: less-differentiated oligodendrocyte precursor-like stem cells and more differentiated astrocyte-like cells.
  • Researchers created models representing these cell types and used various profiling techniques to understand their distinct metabolic programs, identifying specific weaknesses in each type.
  • The study found that astrocyte-like cells are more prone to a type of cell death called ferroptosis, while oligodendrocyte precursor-like cells are sensitive to statins and inhibitors of mitochondrial function, suggesting targeted therapies could improve treatment outcomes for patients with these tumors.
View Article and Find Full Text PDF

Introduction: Racial or ethnic minorities are underrepresented in many health care professions, including physical therapy. Understanding the experiences of minority students in graduate education provides insight into how physical therapy educational programs can promote diversity, equity, and inclusion, which are factors that have been shown to improve patient outcomes. The purpose of this study is to qualitatively analyze and describe the lived experiences of Black student physical therapists (PT) in Texas.

View Article and Find Full Text PDF

Therapeutic resistance remains a major obstacle to preventing progression of H3K27M-altered Diffuse Midline Glioma (DMG). Resistance is driven in part by ALDH-positive cancer stem cells (CSC), with high ALDH1A3 expression observed in H3K27M-mutant DMG biopsies. We hypothesized that ALDH-mediated stemness and resistance may in part be driven by the oncohistone itself.

View Article and Find Full Text PDF

T cell proliferation and cytokine production are bioenergetically and biosynthetically costly. The inability to meet these metabolic demands results in altered differentiation, accompanied by impaired effector function, and attrition of the immune response. Interleukin-17-producing CD4 T cells (T17s) are mediators of host defense, autoimmunity, and antitumor immunity in the setting of adoptive T cell therapy.

View Article and Find Full Text PDF